This finding aligns with the well-established role of promoter hypomethylation in gene derepression (Lou et al., 2014), suggesting that aberrant upregulation of ORAOV1 in HCC may be partly attributable to epigenetic dysregulation in its promoter region. This evidence concerns the gene LTO1 and hepatocellular carcinoma.